CSL

Watch a two-minute video to learn how chronic inflammatory demyelinating polyneuropathy (CIDP) affects the nerves and how a treatment called immunoglobulin therapy works on the immune system to help manage the condition. https://bit.ly/4g0UlVr

Today is Iron Deficiency Day! Did you know that 1 in 3 people worldwide is affected by iron deficiency? This condition, often overlooked, can lead to fatigue, dizziness, and even serious health complications if left untreated. Iron Deficiency Day is a global initiative to raise awareness about the vital role of iron in our health. Iron supports energy, focus, and immune strength, yet many people are unaware of the symptoms of deficiency or how to address them. To mark this important day, patient advocacy groups and scientific organizations across the globe are leading efforts to educate and raise awareness about recognizing and managing iron deficiency. At CSL, we’ve joined the movement by organizing activities across our sites. From offering iron-rich lunches and ferritin tests, to hosting an inspiring online panel discussion on women’s health and iron deficiency, we’re committed to spreading awareness. Our all-woman panel shared personal journeys with iron deficiency, practical tips for monitoring and managing it, and debunked common misconceptions about its impact on women’s health. Let’s work together to ensure that iron deficiency no longer goes unnoticed or undiagnosed. Take a moment today to learn more, raise awareness, and support those affected. Read more here https://bit.ly/3Z8mIJL #IronDeficiencyDay2024 #HealthAwareness #TakeIronSeriously #IronMatters

Since 1916, CSL has been committed to saving lives and improving human health. From our beginnings to today, with our three businesses – CSL Behring, CSL Seqirus and CSL Vifor – we've grown to reach patients in over 100 countries. With a team of 32,000 strong, we're driven by our promise to deliver innovative medicines using the latest scientific advancements. https://bit.ly/3Zo6hdM

Looking for some inspiration? Meet Dee who keeps hiking, cycling and encouraging others who live with Alpha-1 Antitrypsin Deficiency, a rare disease that can impact the lungs and liver. #Alpha-1AwarenessMonth https://lnkd.in/eHd7Be-D #CSL #Alpha1 #RareDiseases

This month, we recognize the trailblazing community of Alpha-1 Antitrypsin Deficiency patients and reflect on the life of Fred Walsh, remembered for his authentic, dedicated advocacy. https://bit.ly/3APhBpX #Alpha-1AwarenessMonth Alpha Net

At CSL, we believe in the power of partnership. We collaborate with patient advocacy groups like the Jeffrey Modell Foundation, EURORDIS and NORD to raise awareness for rare diseases and support those affected. Because early diagnosis is crucial, we’re committed to increasing understanding and providing resources for patients and their families. #PatientStories Learn more here: https://bit.ly/4hZRddB

💡 Did you know that women are more likely to develop iron deficiency than men? In fact, nearly 20% of women of childbearing age have low iron levels due to menstruation and other factors. Iron is essential for staying energetic and focused, but many women may not realize they’re deficient. Learn how to recognize the symptoms and what steps you can take to protect your iron health https://bit.ly/4933YjK #WomenHealth #TakeIronSeriously #IronDeficiency #IronDeficiencyDay2024

For over a century, CSL has supported Australia through seasonal flu and five pandemics via onshore manufacturing and domestic vaccine capacity building. Our state-of-the-art facility in Melbourne, Australia will soon be the heart of Australian seasonal and pandemic influenza vaccine production, and we were proud to welcome Health Minister The Hon Mark Butler MP to tour the site and see our next-generation capabilities. Learn more about what we do at CSL: https://bit.ly/3CFM4Hx #Vaccines #Influenza #PublicHealth #Manufacturing #Melbourne #Australia #DrivenByOurPromise #CSLSeqirus

We were honored to host Massachusetts Public Health Committee Chairwoman Representative Marjorie Decker and Vice-chairwoman Representative Sally Kerans, Representative Vanna Howard, as well as their teams, and the office of Senator John Keenan for a tour of our Waltham, MA R&D site. Their visit was a testament to their commitment to public health, and we are grateful for their interest in our work. Learn more about CSL https://bit.ly/3YW2x1Q. #CSL

Did you know that CKD-aP, a relentless itch affecting up to 70% of dialysis patients, is often overlooked despite its profound impact on quality of life? At CSL Vifor, we’re driving awareness and championing patient-centered care for those affected by this condition. In a recent article for The Parliament Magazine, we highlighted the importance of understanding patient-reported outcomes to address CKD-aP's impact. Joining the conversation, Daniel Gallego, President of the European Kidney Patients’ Federation, shares six actionable recommendations to enhance care for CKD-aP across Europe. Let’s make CKD-aP a priority in kidney care—together, we can go #BeyondItching to improve patients’ lives. Read more https://bit.ly/3UWfIi7